← FDA DRUG APPROVALS

FDA NDA · NDA205388

OMIDRIA

phenylephrine and ketorolac

Sponsor: RAYNER SURGICAL

APPLICATION
NDA205388
TYPE
NDA
ORIGINAL APPROVAL
2014-05-30
LATEST ACTION
2017-12-08
ROUTE
INTRAOCULAR, IRRIGATION
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

OMIDRIA · ReferencePrescription
KETOROLAC TROMETHAMINE EQ 0.3% BASE, PHENYLEPHRINE HYDROCHLORIDE EQ 1% BASE · SOLUTION · IRRIGATION

Approval history

2017-12-08Efficacy · Supplement 6 · priorityLabelAP
2016-10-27Manufacturing (CMC) · Supplement 4AP
2016-07-08Manufacturing (CMC) · Supplement 3 · standardAP
2016-01-15Manufacturing (CMC) · Supplement 2 · standardAP
2015-05-21Manufacturing (CMC) · Supplement 1 · standardLabelAP
2014-05-30Type 4 - New Combination · Original · standardLabelAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →